Literature DB >> 14718531

Histidine 167 is the phosphate acceptor in glucose-6-phosphatase-beta forming a phosphohistidine enzyme intermediate during catalysis.

Abhijit Ghosh1, Jeng-Jer Shieh, Chi-Jiunn Pan, Janice Yang Chou.   

Abstract

The glucose-6-phosphatase (Glc-6-Pase) family comprises two active endoplasmic reticulum (ER)-associated isozymes: the liver/kidney/intestine Glc-6-Pase-alpha and the ubiquitous Glc-6-Pase-beta. Both share similar kinetic properties. Sequence alignments predict the two proteins are structurally similar. During glucose 6-phosphate (Glc-6-P) hydrolysis, Glc-6-Pase-alpha, a nine-transmembrane domain protein, forms a covalently bound phosphoryl enzyme intermediate through His(176), which lies on the lumenal side of the ER membrane. We showed that Glc-6-Pase-beta is also a nine-transmembrane domain protein that forms a covalently bound phosphoryl enzyme intermediate during Glc-6-P hydrolysis. However, the intermediate was not detectable in Glc-6-Pase-beta active site mutants R79A, H114A, and H167A. Using [(32)P]Glc-6-P coupled with cyanogen bromide mapping, we demonstrated that the phosphate acceptor in Glc-6-Pase-beta is His(167) and that it lies inside the ER lumen with the active site residues, Arg(79) and His(114). Therefore Glc-6-Pase-alpha and Glc-6-Pase-beta share a similar active site structure, topology, and mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718531     DOI: 10.1074/jbc.M313271200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Chasing phosphohistidine, an elusive sibling in the phosphoamino acid family.

Authors:  Jung-Min Kee; Tom W Muir
Journal:  ACS Chem Biol       Date:  2011-12-09       Impact factor: 5.100

Review 2.  Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy.

Authors:  Janice Y Chou; Hyun Sik Jun; Brian C Mansfield
Journal:  Nat Rev Endocrinol       Date:  2010-10-26       Impact factor: 43.330

3.  Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice.

Authors:  Wai Han Yiu; Chi-Jiunn Pan; Paul A Mead; Matthew F Starost; Brian C Mansfield; Janice Y Chou
Journal:  J Hepatol       Date:  2009-02-05       Impact factor: 25.083

Review 4.  Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Hum Mutat       Date:  2008-07       Impact factor: 4.878

5.  18F-fluoro-2-deoxy-d-glucose (FDG) uptake. What are we looking at?

Authors:  Gianmario Sambuceti; Vanessa Cossu; Matteo Bauckneht; Silvia Morbelli; AnnaMaria Orengo; Sonia Carta; Silvia Ravera; Silvia Bruno; Cecilia Marini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05       Impact factor: 9.236

Review 6.  Advances in development of new tools for the study of phosphohistidine.

Authors:  Mehul V Makwana; Richmond Muimo; Richard Fw Jackson
Journal:  Lab Invest       Date:  2017-12-04       Impact factor: 5.662

7.  Glucose-6-phosphatase-β, implicated in a congenital neutropenia syndrome, is essential for macrophage energy homeostasis and functionality.

Authors:  Hyun Sik Jun; Yuk Yin Cheung; Young Mok Lee; Brian C Mansfield; Janice Y Chou
Journal:  Blood       Date:  2012-01-12       Impact factor: 22.113

8.  In islet-specific glucose-6-phosphatase-related protein, the beta cell antigenic sequence that is targeted in diabetes is not responsible for the loss of phosphohydrolase activity.

Authors:  J-J Shieh; C-J Pan; B C Mansfield; J Y Chou
Journal:  Diabetologia       Date:  2005-07-13       Impact factor: 10.122

9.  Functional analysis of mutations in a severe congenital neutropenia syndrome caused by glucose-6-phosphatase-β deficiency.

Authors:  Su Ru Lin; Chi-Jiunn Pan; Brian C Mansfield; Janice Yang Chou
Journal:  Mol Genet Metab       Date:  2014-11-26       Impact factor: 4.797

Review 10.  The SLC37 family of sugar-phosphate/phosphate exchangers.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Curr Top Membr       Date:  2014       Impact factor: 3.049

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.